Japan Medical Dynamic Marketing, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3689100000
JPY
471.00
-2 (-0.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
25,114.03
23,177.75
21,307.95
19,193.10
16,738.17
18,083.19
16,728.89
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
25,114.03
23,177.75
21,307.95
19,193.10
16,738.17
18,083.19
16,728.89
Raw Material Cost
10,906.06
9,775.73
8,665.62
7,445.35
6,532.86
6,523.70
5,968.05
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
75.35
41.34
27.54
37.09
49.65
86.76
117.61
Selling and Distribution Expenses
11,529.58
10,631.98
9,807.72
8,442.04
7,431.55
8,319.49
7,921.49
Other Expenses
88.46
83.31
63.54
44.85
41.70
38.39
36.67
Total Expenditure (Excl Depreciation)
23,395.63
21,282.13
19,136.28
16,372.95
14,431.09
15,313.83
14,373.87
Operating Profit (PBDIT) excl Other Income
1718.4
1895.6
2171.7
2820.1
2307.1
2769.4
2355
Other Income
-44.58
86.78
-22.62
-120.30
-30.91
-11.42
51.94
Operating Profit (PBDIT)
3,182.80
3,428.88
3,551.86
3,962.01
3,526.86
4,021.70
3,452.75
Interest
75.35
41.34
27.54
37.09
49.65
86.76
117.61
Exceptional Items
-1,778.41
-155.57
-204.71
245.66
-54.01
69.42
0.00
Gross Profit (PBDT)
14,207.98
13,402.02
12,642.33
11,747.75
10,205.32
11,559.48
10,760.84
Depreciation
1,671.44
1,595.18
1,549.81
1,420.78
1,388.83
1,388.58
1,165.84
Profit Before Tax
-342.40
1,636.79
1,769.80
2,749.80
2,034.37
2,615.78
2,169.30
Tax
126.66
331.30
334.07
608.10
353.63
428.31
172.12
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-461.80
1,271.68
1,423.72
2,135.69
1,664.52
2,164.95
1,984.58
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-461.80
1,271.68
1,423.72
2,135.69
1,664.52
2,164.95
1,984.58
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-7.26
33.81
12.01
6.01
16.23
22.52
12.59
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-469.06
1,305.49
1,435.73
2,141.71
1,680.74
2,187.47
1,997.17
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
24,679.26
25,511.32
23,161.63
21,386.44
18,628.77
16,928.30
15,188.80
Earnings per share (EPS)
-17.54
48.31
54.03
80.95
63.09
82.02
75.17
Diluted Earnings per share
-17.54
48.31
54.03
80.95
63.09
82.02
75.17
Operating Profit Margin (Excl OI)
6.2%
7.54%
9.5%
13.87%
12.96%
14.62%
13.36%
Gross Profit Margin
5.29%
13.94%
15.58%
21.73%
20.45%
22.14%
19.94%
PAT Margin
-1.84%
5.49%
6.68%
11.13%
9.94%
11.97%
11.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 8.35% vs 8.78% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is -135.93% vs -9.07% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -3.43% vs -6.50% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 82.32% vs 50.18% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Japan Medical Dynamic Marketing, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
25,114.03
2,978.63
22,135.40
743.14%
Other Operating Income
0.00
0.00
0.00
Total Operating income
25,114.03
2,978.63
22,135.40
743.14%
Raw Material Cost
10,906.06
1,347.99
9,558.07
709.06%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
75.35
0.00
75.35
Selling and Distribution Expenses
11,529.58
1,224.26
10,305.32
841.76%
Other Expenses
88.46
53.68
34.78
64.79%
Total Expenditure (Excl Depreciation)
23,395.63
3,109.04
20,286.59
652.50%
Operating Profit (PBDIT) excl Other Income
1,718.41
-130.41
1,848.82
1,417.70%
Other Income
-44.58
175.46
-220.04
-125.41%
Operating Profit (PBDIT)
3,182.80
95.76
3,087.04
3,223.73%
Interest
75.35
0.00
75.35
Exceptional Items
-1,778.41
0.00
-1,778.41
Gross Profit (PBDT)
14,207.98
1,630.63
12,577.35
771.32%
Depreciation
1,671.44
50.70
1,620.74
3,196.73%
Profit Before Tax
-342.40
45.05
-387.45
-860.04%
Tax
126.66
-58.19
184.85
317.67%
Provisions and contingencies
0
0
0.00
Profit After Tax
-461.80
103.25
-565.05
-547.26%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-461.80
103.25
-565.05
-547.26%
Share in Profit of Associates
0
0
0.00
Minority Interest
-7.26
0.00
-7.26
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-469.06
103.25
-572.31
-554.30%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
24,679.26
8,984.95
15,694.31
174.67%
Earnings per share (EPS)
-17.54
1.11
-18.65
-1,680.18%
Diluted Earnings per share
-17.54
1.11
-18.65
-1,680.18%
Operating Profit Margin (Excl OI)
6.20%
-4.38%
0.00
10.58%
Gross Profit Margin
5.29%
3.21%
0.00
2.08%
PAT Margin
-1.84%
3.47%
0.00
-5.31%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 2,511.40 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 8.35% vs 8.78% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit -46.91 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -135.93% vs -9.07% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 322.74 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -3.43% vs -6.50% in Mar 2024

Annual - Interest
Interest 7.53 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 82.32% vs 50.18% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.20%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has fallen from Mar 2024